Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Tobacco use as drug addiction: the scientific foundation.

Henningfield JE, Fant RV.

Nicotine Tob Res. 1999;1 Suppl 2:S31-5. Review.

PMID:
11768184
2.

Nicotine psychopharmacology: policy and regulatory.

Henningfield JE, Zeller M.

Handb Exp Pharmacol. 2009;(192):511-34. doi: 10.1007/978-3-540-69248-5_18. Review.

PMID:
19184661
3.

Nicotine addiction.

Benowitz NL.

Prim Care. 1999 Sep;26(3):611-31. Review.

PMID:
10436290
4.

Cigarette smoking and nicotine addiction.

Benowitz NL.

Med Clin North Am. 1992 Mar;76(2):415-37. Review.

PMID:
1548969
5.

Tobacco addiction: implications for treatment and cancer prevention.

Cinciripini PM, Hecht SS, Henningfield JE, Manley MW, Kramer BS.

J Natl Cancer Inst. 1997 Dec 17;89(24):1852-67. Review.

PMID:
9414173
6.

Reducing tobacco addiction through tobacco product regulation.

Henningfield JE, Benowitz NL, Connolly GN, Davis RM, Gray N, Myers ML, Zeller M.

Tob Control. 2004 Jun;13(2):132-5. Review.

7.

Tobacco use and dependence.

Sohn M, Hartley C, Froelicher ES, Benowitz NL.

Semin Oncol Nurs. 2003 Nov;19(4):250-60. Review.

PMID:
14702859
8.

Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?

Sims TH, Fiore MC.

CNS Drugs. 2002;16(10):653-62. Review.

PMID:
12269859
9.

Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.

Le Houezec J.

Int J Tuberc Lung Dis. 2003 Sep;7(9):811-9. Review.

PMID:
12971663
10.

Managing nicotine addiction.

Kotlyar M, Hatsukami DK.

J Dent Educ. 2002 Sep;66(9):1061-73. Review.

11.

[Tobacco dependence].

Saito T, Murakami S.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 1998 Oct;33(5):549-56. Review. Japanese.

PMID:
9844375
12.

Prevention of nicotine addiction: neuropsychopharmacological issues.

Henningfield JE, Jude NR.

Nicotine Tob Res. 1999;1 Suppl 1:S41-8. Review.

PMID:
11072403
13.

Internal tobacco industry research on olfactory and trigeminal nerve response to nicotine and other smoke components.

Megerdichian CL, Rees VW, Wayne GF, Connolly GN.

Nicotine Tob Res. 2007 Nov;9(11):1119-29. Review.

PMID:
17978985
14.

Conceptual and methodological considerations for tobacco addiction research.

Grunberg NE, Acri JB.

Br J Addict. 1991 May;86(5):637-41. Review.

PMID:
1859932
15.

Treating tobacco dependence: state of the science and new directions.

Lerman C, Patterson F, Berrettini W.

J Clin Oncol. 2005 Jan 10;23(2):311-23. Review.

PMID:
15637394
16.

Pharmacologic determinants of tobacco self-administration by humans.

Henningfield JE, Goldberg SR.

Pharmacol Biochem Behav. 1988 May;30(1):221-6. Review.

PMID:
3051047
17.

Nicotine delivery kinetics and abuse liability.

Henningfield JE, Keenan RM.

J Consult Clin Psychol. 1993 Oct;61(5):743-50. Review.

PMID:
8245272
18.

Vaccination against nicotine: an emerging therapy for tobacco dependence.

Maurer P, Bachmann MF.

Expert Opin Investig Drugs. 2007 Nov;16(11):1775-83. Review.

PMID:
17970637
19.

Potential reduction exposure products and FDA tobacco and regulation: a CNS call to action.

Heath J, Andrews J, Balkstra CR.

Clin Nurse Spec. 2004 Jan-Feb;18(1):40-8; quiz 49-50. Review.

PMID:
15061445
20.

Tobacco industry manipulation of nicotine dosing.

Wayne GF, Carpenter CM.

Handb Exp Pharmacol. 2009;(192):457-85. doi: 10.1007/978-3-540-69248-5_16. Review.

PMID:
19184659

Supplemental Content

Support Center